UPClytics
Alle Fälle anzeigen

APL 12116/2024

·EP2697391: METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE

Verfahrensdetails
Status
Verfahrensart
Berufung
Kategorie
Hauptberufung
Parteien
Kläger
Vertreter: Tilman Müller-Stoy (Bardehle Pagenberg); Axel B. Berger (Bardehle Pagenberg)
Beklagte
Vertreter: Cameron Marshall (Carpmaels & Ransford); Agathe Michel-De Cazotte (Carpmaels & Ransford)
Division
Court of Appeal
Richter
Technology
Biotechnology
Sprache
Erste Entscheidung
17. Apr. 2024
Entscheidungen
  • 2024-04-17
    BerufungsentscheidungAppeal RoP220.1

    The UPC Court of Appeal upheld the President of the Court of First Instance's refusal to change the language of proceedings from German to English in 10x Genomics' provisional measures application against Curio Bioscience concerning EP2697391, finding that the interests of the parties were balanced and the defendant's position was the decisive factor.

    Rechtsfragen:Change of language of proceedings (Art. 49(5) UPCA)Fairness in language selectionDefendant's position as decisive factor in balanced cases
  • 2024-04-17
    BerufungsentscheidungAppeal RoP220.1

    Court of Appeal set aside the President of the CFI's order refusing to change the language of proceedings from German to English in the provisional measures case before the Düsseldorf Local Division. The CoA held that, considering all relevant circumstances (Curio Bioscience is a US company with no connection to Germany, the patent was granted in English, the technology field predominantly uses English), the language of proceedings shall be English. The impugned order of 26 February 2024 was set aside and the language changed to English.

    Rechtsfragen:Change of language of proceedings on appeal (Art.49(5) UPCA)Relevance of stage of proceedings to language changeParties' language qualifications as irrelevant factorBalancing interests in language change
Dokumente
  • 410DE28BFAD1A8B205DCE14353C75FC1_de.pdf2024-04-17DE
  • ORDER%20final%20EN.pdf2024-04-17ENGLISH
10x Genomics, Inc. v Curio Bioscience Inc. — UPC APL 12116/2024 | UPClytics